ライブ

Endpoints NewsSanofi R&D leader Houman Ashrafian to depart, Paulo Fontoura to take the reins FierceBiotechSanofi's R&D chief Ashrafian to hit the exit as new CEO seeks to fix stuttering pipeline with Roche alum Endpoints NewsNura Bio gets $73.8M to advance SARM1 inhibitors for neurodegeneration BioPharma DiveThe first 14 days: How specialty programs set patients up for success BioPharma DiveFrom episodes to a lifetime: How AI can enable women’s health brands to build a partnership that lasts Clinical OMICsBirth Characteristics Highlight Early-Onset Colorectal Cancer Risk FierceBiotechA 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition FierceBiotechInsilico lands heavily backloaded $2.5B AI drug discovery deal with SK Biopharm FierceBiotechFDA Breakthrough Therapy and RMAT: Strategic Decisions That Can Accelerate Oncology Development eLifeExploration of precision coregulator TR-FRET identifies diverse signatures for LXR ligands relevant to discovery of nonlipogenic ABCA1 inducers AgilentHow Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics - Yahoo Finance CellExpansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy

Clinical OMICs 2026年6月22日

Birth Characteristics Highlight Early-Onset Colorectal Cancer Risk

Several factors identifiable at birth increase the risk of colorectal cancer at a young age, while having a foreign-born mother may reduce this risk. The post B...

Several factors identifiable at birth increase the risk of colorectal cancer at a young age, while having a foreign-born mother may reduce this risk. The post Birth Characteristics Highlight Early-Onset Colorectal Cancer Risk appeared first on Inside Precision Medicine .